Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8551–8600 of 18654
the Company announced that the Board of Directors of the Company appointed George N. Mattson to serve as Chief Executive Officer of Wheels Up Partners LLC
On September 14, 2023, the Board of Directors of Kronos Bio, Inc. (the “Company”) appointed Sandra A. Gardiner as the Company’s interim Chief Financial Officer, as well as the Company’s principal financial officer and principal accounting officer, effective at the close of business on September 15, 2023.
Gerry P. Smith, the Chief Executive Officer of the Company (“CEO”), began a temporary medical leave of absence to undergo a medical procedure that requires several weeks of recovery.
the Board of Directors of the Company (the “Board”) has appointed Joseph S. Vassalluzzo, the Company’s non-executive Chair of the Board, to assume Mr. Smith’s authority and responsibilities until Mr. Smith returns from his medical leave.
Jack Dorsey, the Company’s Block Head and Chairperson, will also serve as the Square Head.
Alyssa Henry, the Square Chief Executive Officer of Block, Inc. (the “Company”) will depart the Company effective October 2, 2023.
Mr. Camden replaces James J. McKinney, who will serve as a senior advisor to the Company to support a smooth transition.
appointment of Bradley T. Camden, Senior Vice President and Treasurer, as Interim Chief Financial Officer and the Company’s principal financial officer, effective September 13, 2023.
Sebastian Holl is named as the interim Chief Executive Officer and member of the Board
Jeffrey Lubchansky was removed immediately as Chief Executive Officer of the Company and sole member of the Company Board of Directors (the “Board”).
Effective September 18, 2023, ImmunoGen, Inc. (the “Company”) appointed Lauren White as Senior Vice President and Chief Financial Officer and designated her as the Company’s principal financial officer.
On September 18, 2023, AlTi Global, Inc. (the “Company”) announced the appointment of Stephen D. Yarad as Chief Financial Officer.
appointed Craig R. Benson, a member of the Company’s Board, as Interim Chief Executive Officer, effective immediately.
resulting in Chris Rondeau’s departure as the Company’s CEO, effective as of September 15, 2023.
Effective immediately following Ms. Kinder’s departure, Todd Wilson, the Company’s Chief Financial Officer, will assume the responsibilities of principal accounting officer.
Also on September 15, 2023, the Company appointed Mathieu Riffel (age 38) as Acting Chief Financial Officer, effective immediately.
the Company entered into a Retention Agreement with Brad Bollner, the Company's Vice President of Finance and, effective October 1, 2023, the Company's interim Chief Financial Officer
approved the grant to John Moore, the Company's Head of Coffee and, effective October 1, 2023, the interim Chief Executive Officer
On September 11, 2023, David P. Jenkins notified Gardiner Healthcare Acquisitions Corp., a Delaware corporation (the “Company”), of his decision to resign as Chief Financial Officer (“CFO”), effective September 19, 2023, to pursue other opportunities.
On September 13, 2023, Coherent Corp. (the “Company”) and Mary Jane Raymond, the Company’s Chief Financial Officer, Treasurer and principal financial officer (“CFO”), mutually agreed that she would conclude her services as the Company’s CFO as of September 29, 2023 (the “Effective Date”).
On September 13, 2023, the Board of Directors of the Company (the “Board”) appointed Richard Martucci (age 55), the Company’s Senior Vice President, Business Operations, to serve as its interim Chief Financial Officer and Treasurer and principal financial officer (“Interim CFO”), effective as of September 30, 2023 and until a permanent successor is identified.
the principal financial officer of World Wrestling Entertainment, Inc. (n/k/a World Wresting Entertainment, LLC) (the “Company”), Frank A. Riddick III, ceased to be an officer of the Company
On September 15, 2023, Five Point Holdings, LLC (the “Company”) announced the appointment of Kim Tobler as Chief Financial Officer, Treasurer and Vice President of the Company, effective immediately.
the following individuals were appointed to serve as executive officers of the Company: Name Position Wensheng Fan Chief Executive Officer and Director
Nils Windler Chief Financial Officer
Anthony Capone resigned as the Chief Executive Officer of DocGo Inc. (the “Company”) and from all other positions with the Company due to personal reasons.
On September 15, 2023, the Board of Directors of the Company (the “Board”) appointed Lee Bienstock, the Company’s current President and Chief Operating Officer, as the Chief Executive Officer of the Company, effective immediately.
the Board of Directors (the “Board”) of the Company had appointed Robert C. Flexon, the Company’s then current Chairman of the Board, to serve as Interim President and Chief Executive Officer, effective August 22, 2023.
The Company engaged Jade Barnwell as its Chief Financial Officer as set forth in the Current Report on Form 8-K filed August 3, 2023.
On June 16, 2023, the registrant (“Laser Photonics”), with the concurrence of its Audit Committee, discontinued its relationship with William Campbell who was serving without any employment or consulting agreement with Laser Photonics as Interim CFO.
On September 14, 2023, James W. Creamer III voluntarily resigned as the Company’s Chief Financial Officer.
On September 11, 2023, Seth Van Voorhees, Ph.D., resigned from his position as the Chief Financial Officer of the Company. His resignation will be effective as of September 30, 2023, in order to facilitate a smooth transition.
on September 13, 2023, the Company appointed Richard Narido, 45, to serve as Interim Chief Financial Officer of the Company.
The Board also appointed Geoffrey C. Gillespie as Interim Chief Financial Officer and Puja Leekha as Interim Chief Legal Officer, each effective immediately.
On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.
Also on September 11, 2023, the Board appointed Catherine M. Burzik, the current Chair of the Board, as Interim Chief Executive Officer, effectively immediately.
On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.
Effective with Mr. Colpitts’ departure, Thad Trent, who has served as Executive Vice President, Chief Financial Officer, and Treasurer of the Company since February 2021, will assume the additional role of principal accounting officer.
Effective September 12, 2023, the Board of Directors (the “Board”) of Legacy Housing Corporation (“Legacy” or the “Company”) appointed Jeff Fiedelman, age 54, as Chief Financial Officer (“CFO”).
Mr. Fiedelman replaces Ronald Arrington, who stepped down as CFO on September 11, 2023.
Mr. Xianchang Ma, previously the Chief Executive Officer, President, Chief Financial Officer and Director of the Company, passed away on August 3, 2023.
On September 13, 2023, the Board resolved to appoint Ms. Qiuping Lu as the Chief Executive Officer, President, Chief Financial Officer of the Company.
has appointed Steven Gatoff as Chief Financial Officer of the Company, effective September 14, 2023
to replace Robert G. Barbieri, who is leaving the Company to pursue other interests.
On September 13, 2023, effective immediately, Chunyi (Charlie) Hao submitted his resignation as Chief Executive Officer.
effective as of August 21, 2023 (the “Termination Date”), Josh Lehrer, M.D., the former President, Chief Executive Officer and member of the Board of Directors of Graphite Bio, Inc. (the “Company”), separated from his employment and all officer and director positions with the Company.
effective September 15, 2023, Daniel Zubeck, the Company’s Chief Financial Officer, will resign from the Company.
Michael J. Lotz, the Company’s President, will serve as interim Chief Financial Officer.
Effective concurrently with Mr. Ford’s designation as the Company’s principal accounting officer, the designation of Mr. John Collins in that capacity ended.
announced that Uneek Mehra had joined the Company as Chief Financial and Business Officer, Principal Financial Officer, Principal Accounting Officer, and Assistant Secretary of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.